• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鸭病毒性肝炎二价灭活疫苗的研制与评价

[Development and evaluation of an inactivated bivalent vaccine against duck viral hepatitis].

作者信息

Yin Fenggui, Jing Li, Zhang Shuang, Yu Meng, Zhang Wanlin, Fan Guobing, Dong Xiukai, Liu Wenjun

出版信息

Sheng Wu Gong Cheng Xue Bao. 2015 Nov;31(11):1579-88.

PMID:26939441
Abstract

The rapid mutation and widely spread of duck hepatitis A virus (DHAV) lead to the vast economic loss of the duck industry. To prepare and evaluate bivalent inactivated vaccine laboratory products of DHAV, 6 strains were screened from 201 DHAV-1 strains and 38 DHAV-3 strains by using serotype epidemiological analysis in most of the duck factory. Vaccine candidate strains were selected by ELD50 and LD50 tests in the 6 strains. Continuously passaged, the 5th passaged duck embryos bodies grinding fluid was selected as vaccine virus seeds. The virus seeds were treated with formaldehyde and water in oil in water (W/O/W) emulsions, making into three batches of two bivalent inactivated vaccine laboratory products. The safety test, antibody neutralization test, challenged protection and cross immune protection experiment suggested that the vaccines possessed good safety, and neutralizing antibodies were detected at 7th day and the challenged protection rate reached 90% to 100% at the 14th and 21st day. Moreover, immune duration of ducklings lasted more than five weeks. However, cross-immunity protection experiments with DHAV-SH and DHAV-FS only had 20%-30%. The two bivalent inactivated vaccine laboratory products of duck viral hepatitis were effective and reliable, providing a new method as well as a new product for DHAV prevention and control.

摘要

鸭甲型肝炎病毒(DHAV)的快速变异和广泛传播给养鸭业带来了巨大的经济损失。为制备和评价DHAV二价灭活疫苗实验室产品,通过对多数鸭场进行血清型流行病学分析,从201株DHAV - 1毒株和38株DHAV - 3毒株中筛选出6株。通过对这6株毒株进行ELD50和LD50试验筛选候选疫苗毒株。连续传代后,选取第5代鸭胚研磨液作为疫苗病毒种子。将病毒种子用甲醛处理并制成水包油包水(W/O/W)乳剂,制成三批两种DHAV二价灭活疫苗实验室产品。安全性试验、抗体中和试验、攻毒保护及交叉免疫保护试验表明,该疫苗安全性良好,7日龄可检测到中和抗体,14日龄和21日龄攻毒保护率达90%至100%。此外,雏鸭免疫期持续超过5周。然而,与DHAV - SH和DHAV - FS的交叉免疫保护试验仅有20% - 30%。两种鸭病毒性肝炎二价灭活疫苗实验室产品有效可靠,为DHAV的防控提供了新方法和新产品。

相似文献

1
[Development and evaluation of an inactivated bivalent vaccine against duck viral hepatitis].鸭病毒性肝炎二价灭活疫苗的研制与评价
Sheng Wu Gong Cheng Xue Bao. 2015 Nov;31(11):1579-88.
2
Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis A virus types 1 and 3 in ducklings.针对鸭肝炎 A 病毒 1 型和 3 型的二价活疫苗对雏鸭的保护效力。
Vet Microbiol. 2018 Feb;214:108-112. doi: 10.1016/j.vetmic.2017.12.018. Epub 2017 Dec 26.
3
Molecular epidemiology of duck hepatitis a virus types 1 and 3 in China, 2010-2015.中国 2010-2015 年鸭甲型肝炎病毒 1 型和 3 型的分子流行病学研究。
Transbound Emerg Dis. 2018 Feb;65(1):10-15. doi: 10.1111/tbed.12741. Epub 2017 Oct 27.
4
Live attenuated duck hepatitis virus vaccine in breeder ducks: Protective efficacy and kinetics of maternally derived antibodies.商品代蛋鸭用鸭肝炎活疫苗免疫效力及母源抗体消长规律研究。
Vet Microbiol. 2018 Jun;219:107-112. doi: 10.1016/j.vetmic.2018.04.021. Epub 2018 Apr 14.
5
Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections.鸭甲型肝炎病毒3型疫苗的研制及其用于保护雏鸭免受感染。
Vaccine. 2009 Nov 12;27(48):6688-94. doi: 10.1016/j.vaccine.2009.08.092. Epub 2009 Sep 9.
6
Development of a live attenuated duck hepatitis A virus type 3 vaccine (strain SD70).一株鸭甲型肝炎病毒 3 型(SD70 株)活疫苗的研制
Vaccine. 2020 Jun 19;38(30):4695-4703. doi: 10.1016/j.vaccine.2020.05.030. Epub 2020 May 20.
7
Development of the first officially licensed live attenuated duck hepatitis A virus type 3 vaccine strain HB80 in China and its protective efficacy against DHAV-3 infection in ducks.中国首个官方许可的减毒鸭甲型肝炎病毒 3 型活疫苗株 HB80 的研发及其对鸭 DHAV-3 感染的保护效力。
Poult Sci. 2024 Oct;103(10):104087. doi: 10.1016/j.psj.2024.104087. Epub 2024 Jul 11.
8
Comparative pathogenicity of different subtypes of duck hepatitis A virus in Pekin ducklings.不同亚型鸭甲肝病毒在雏北京鸭中的致病性比较。
Vet Microbiol. 2019 Jan;228:181-187. doi: 10.1016/j.vetmic.2018.11.030. Epub 2018 Dec 1.
9
Evidence of possible vertical transmission of duck hepatitis A virus type 1 in ducks.鸭甲型肝炎病毒 1 型在鸭子中可能存在垂直传播的证据。
Transbound Emerg Dis. 2021 Mar;68(2):267-275. doi: 10.1111/tbed.13708. Epub 2020 Jul 11.
10
Identification of a conserved neutralizing linear B-cell epitope in the VP1 proteins of duck hepatitis A virus type 1 and 3.1型和3型鸭甲型肝炎病毒VP1蛋白中保守中和线性B细胞表位的鉴定
Vet Microbiol. 2015 Nov 18;180(3-4):196-204. doi: 10.1016/j.vetmic.2015.09.008. Epub 2015 Sep 21.

引用本文的文献

1
A meta-analysis for vaccine protection rate of duck hepatitis a virus in mainland China in 2009-2021.2009-2021 年中国大陆鸭肝炎病毒疫苗保护率的荟萃分析。
BMC Vet Res. 2023 Sep 29;19(1):179. doi: 10.1186/s12917-023-03744-8.